Literature DB >> 35951446

Are Unequal Policies in Pre-Exposure Prophylaxis Uptake Needed to Improve Equality? An Examination Among Men Who Have Sex with Men in Los Angeles County.

Anthony Nguyen1, Emmanuel Fulgence Drabo2, Wendy H Garland3, Corrina Moucheraud4, Ian W Holloway5, Arleen Leibowitz6, Sze-Chuan Suen1.   

Abstract

Racial and ethnic minority men who have sex with men (MSM) are disproportionately affected by HIV/AIDS in Los Angeles County (LAC), an important epicenter in the battle to end HIV. We examine tradeoffs between effectiveness and equality of pre-exposure prophylaxis (PrEP) allocation strategies among different racial and ethnic groups of MSM in LAC and provide a framework for quantitatively evaluating disparities in HIV outcomes. To do this, we developed a microsimulation model of HIV among MSM in LAC using county epidemic surveillance and survey data to capture demographic trends and subgroup-specific partnership patterns, disease progression, patterns of PrEP use, and patterns for viral suppression. We limit analysis to MSM, who bear most of the burden of HIV/AIDS in LAC. We simulated interventions where 3000, 6000, or 9000 PrEP prescriptions are provided annually in addition to current levels, following different allocation scenarios to each racial/ethnic group (Black, Hispanic, or White). We estimated cumulative infections averted and measures of equality, after 15 years (2021-2035), relative to base case (no intervention). By comparing allocation strategies on the health equality impact plane, we find that, of the policies evaluated, targeting PrEP preferentially to Black individuals would result in the largest reductions in incidence and disparities across the equality measures we considered. This result was consistent over a range of PrEP coverage levels, demonstrating that there are "win-win" PrEP allocation strategies that do not require a tradeoff between equality and efficiency.

Entities:  

Keywords:  AIDS; HIV; MSM; disparities; microsimulation; pre-exposure prophylaxis

Mesh:

Substances:

Year:  2022        PMID: 35951446      PMCID: PMC9419964          DOI: 10.1089/apc.2022.0011

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.944


  33 in total

1.  The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model.

Authors:  Robert T Koppenhaver; Stephen W Sorensen; Paul G Farnham; Stephanie L Sansom
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

3.  Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.

Authors:  Samuel M Jenness; Kevin M Maloney; Dawn K Smith; Karen W Hoover; Steven M Goodreau; Eli S Rosenberg; Kevin M Weiss; Albert Y Liu; Darcy W Rao; Patrick S Sullivan
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

4.  The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Authors:  Jessie L Juusola; Margaret L Brandeau; Douglas K Owens; Eran Bendavid
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

5.  Impact of Improved HIV Care and Treatment on PrEP Effectiveness in the United States, 2016-2020.

Authors:  Nidhi Khurana; Emine Yaylali; Paul G Farnham; Katherine A Hicks; Benjamin T Allaire; Evin Jacobson; Stephanie L Sansom
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-01       Impact factor: 3.731

6.  Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.

Authors:  Karam C Mounzer; Jennifer S Fusco; Ricky K Hsu; Laurence Brunet; Vani Vannappagari; Kevin R Frost; Mark S Shaefer; Alex Rinehart; Keith Rawlings; Gregory P Fusco
Journal:  AIDS Patient Care STDS       Date:  2021-10-04       Impact factor: 5.078

7.  Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California : Mind the Gaps: Cobertura de recetas e incidencia de VIH entre pacientes recibiendo profilaxis pre-exposición de un centro de salud grande y federalmente calificado en Los Ángeles, CA.

Authors:  Chelsea L Shover; Steven Shoptaw; Marjan Javanbakht; Sung-Jae Lee; Robert K Bolan; Nicole J Cunningham; Matthew R Beymer; Michelle A DeVost; Pamina M Gorbach
Journal:  AIDS Behav       Date:  2019-10

8.  Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance.

Authors:  Virginie Supervie; Meagan Barrett; James S Kahn; Godfrey Musuka; Themba Lebogang Moeti; Lesego Busang; Lesogo Busang; Sally Blower
Journal:  Sci Rep       Date:  2011-12-07       Impact factor: 4.379

9.  PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial.

Authors:  Michael Pickles; Anne Cori; William J M Probert; Rafael Sauter; Robert Hinch; Sarah Fidler; Helen Ayles; Peter Bock; Deborah Donnell; Ethan Wilson; Estelle Piwowar-Manning; Sian Floyd; Richard J Hayes; Christophe Fraser
Journal:  PLoS Comput Biol       Date:  2021-09-02       Impact factor: 4.779

10.  Effect of Racial Inequities in Pre-exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex With Men: A Modeling Study.

Authors:  William C Goedel; Maximilian R F King; Mark N Lurie; Amy S Nunn; Philip A Chan; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.